XML 287 R55.htm IDEA: XBRL DOCUMENT
v3.22.4

Revenue (Revenue Disaggregation by Geographical Region and Revenue Type) (Details) - USD ($) $ in Millions | 12 Months Ended
--- | ---
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020
Disaggregation of Revenue [Line Items] |  |  |
Sales | $ 31,471 | $ 29,453 | $ 22,284
North America |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Sales | 13,968 | 11,829 | 9,011
Western Europe |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Sales | 6,910 | 6,965 | 5,323
Other developed markets |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Sales | 1,467 | 1,475 | 1,299
High-growth markets |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Sales | 9,126 | 9,184 | 6,651
Recurring |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Sales | 23,717 | 21,795 | 15,978
Nonrecurring |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Sales | 7,754 | 7,658 | 6,306
Environmental & Applied Solutions |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Sales | 4,800 |  |
Operating segments | Biotechnology |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Sales | 8,758 | 8,570 | 5,276
Operating segments | Biotechnology | North America |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Sales | 3,054 | 2,899 | 1,880
Operating segments | Biotechnology | Western Europe |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Sales | 2,645 | 2,497 | 1,683
Operating segments | Biotechnology | Other developed markets |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Sales | 358 | 368 | 313
Operating segments | Biotechnology | High-growth markets |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Sales | 2,701 | 2,806 | 1,400
Operating segments | Biotechnology | Recurring |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Sales | 6,958 | 6,772 | 4,299
Operating segments | Biotechnology | Nonrecurring |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Sales | 1,800 | 1,798 | 977
Operating segments | Life Sciences |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Sales | 7,036 | 6,388 | 5,300
Operating segments | Life Sciences | North America |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Sales | 3,154 | 2,534 | 2,039
Operating segments | Life Sciences | Western Europe |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Sales | 1,377 | 1,540 | 1,256
Operating segments | Life Sciences | Other developed markets |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Sales | 506 | 508 | 441
Operating segments | Life Sciences | High-growth markets |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Sales | 1,999 | 1,806 | 1,564
Operating segments | Life Sciences | Recurring |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Sales | 4,220 | 3,756 | 3,101
Operating segments | Life Sciences | Nonrecurring |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Sales | 2,816 | 2,632 | 2,199
Operating segments | Diagnostics |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Sales | 10,849 | 9,844 | 7,403
Operating segments | Diagnostics | North America |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Sales | 5,522 | 4,365 | 3,182
Operating segments | Diagnostics | Western Europe |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Sales | 1,837 | 1,840 | 1,375
Operating segments | Diagnostics | Other developed markets |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Sales | 481 | 481 | 423
Operating segments | Diagnostics | High-growth markets |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Sales | 3,009 | 3,158 | 2,423
Operating segments | Diagnostics | Recurring |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Sales | 9,698 | 8,607 | 6,143
Operating segments | Diagnostics | Nonrecurring |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Sales | 1,151 | 1,237 | 1,260
Operating segments | Environmental & Applied Solutions |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Sales | 4,828 | 4,651 | 4,305
Operating segments | Environmental & Applied Solutions | North America |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Sales | 2,238 | 2,031 | 1,910
Operating segments | Environmental & Applied Solutions | Western Europe |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Sales | 1,051 | 1,088 | 1,009
Operating segments | Environmental & Applied Solutions | Other developed markets |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Sales | 122 | 118 | 122
Operating segments | Environmental & Applied Solutions | High-growth markets |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Sales | 1,417 | 1,414 | 1,264
Operating segments | Environmental & Applied Solutions | Recurring |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Sales | 2,841 | 2,660 | 2,435
Operating segments | Environmental & Applied Solutions | Nonrecurring |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Sales | $ 1,987 | $ 1,991 | $ 1,870

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_DisaggregationOfRevenueLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 4 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 5 -URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 924 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 11.L) -URI https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856 + Details
Name: | us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | srt_StatementGeographicalAxis=srt_NorthAmericaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=dhr_WesternEuropeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=dhr_OtherdevelopedmarketsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=dhr_HighgrowthmarketsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=dhr_RevenuefromContractwithCustomerMeasurementRecurringMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=dhr_RevenuefromContractwithCustomerMeasurementNonrecurringMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=dhr_EnvironmentalAppliedSolutionsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=dhr_BiotechnologyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=dhr_LifeSciencesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=dhr_DiagnosticsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |